Search for: "Wyeth Pharmaceuticals, Incorporated" Results 21 - 40 of 44
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 May 2008, 1:03 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Indian Patent Office decisions now searchable and downloadable: (Indian Patent Oppositions), (Generic Pharmaceuticals & IP), (Spicy IP), Institute for Progress study on inter partes re-examination: (Peter Zura's 271 Patent Blog), (IAM), (Hal Wegner) Nintendo loses patent suit over 3D controller; Anascape awarded $21M in damages:… [read post]
23 Oct 2008, 9:03 am
§343-1(a) allows state enforcement of FDCA violations in the food area, and (b) a private action for violating the state consumer fraud statute, incorporating the standards of California's "little FDCA" statute (also known as the Sherman Act), which in turn just happens to incorporate the FDA's food standards, is a matter of "state," not "federal," enforcement. [read post]
29 Apr 2009, 2:06 am
Goodman's employment with Pfizer for which indemnity or contribution is provided by law or Pfizer's articles of incorporation or corporate by-laws; and(6) any other claim that may not be waived by private agreement without judicial or governmental supervision.5. [read post]
26 May 2015, 7:42 am
  This one addresses how to incorporate genetic variation into the design and implementation of clinical investigations. [read post]
2 Sep 2010, 8:35 am by Stefanie Levine
Patent No. 5,623,600 owned by Trend Micro, Incorporated and entitled VIRUS DETECTION AND REMOVAL APPARATUS FOR COMPUTER NETWORKS. [read post]
27 Mar 2019, 1:00 am by Thaddeus Mason Pope, JD, PhD
Pharmaceutical Pricing Jaime King, University of California Hastings College of the Law, The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs Marc Rodwin, Suffolk University Law School, Controlling Pharmaceutical Prices: What the U.S. [read post]
15 Jan 2015, 9:57 am by Maureen Johnston
At its Conference on January 16, 2015, the Court will consider petitions seeking review of issues such as liability for a priest’s failure to report inappropriate sexual conduct, scope of the exhaustion requirement in a takings claim, the Heck v. [read post]
16 Aug 2009, 11:23 am
Specific performance against the buyer was rarely incorporated into acquisition agreements, not to mention the absence of any bank willing to agree to specific performance with respect to its obligations. [read post]
27 Apr 2007, 12:04 pm
By Hal WegnerBefore an overflow hearing room on an internationally available web broadcast, Chairman Howard Berman of the House Judiciary Subcommittee relevant to patents hosted a most informative and candid hearing yesterday afternoon joined by roughly ten of his committee colleagues, including Rep. [read post]
13 Sep 2007, 10:48 am
Thus, pharmaceutical (and other) manufacturers would have faced a horde of New Jersey-only class actions brought on behalf of third party payers.Not any more.Operating Engineers places imposing barriers in the way of class certification of consumer fraud claims involving mass marketed products - especially claims brought by large institutional plaintiffs such as third-party payers.The court first reiterated that "predominance" could not focus narrowly on the conduct of defendants… [read post]
9 Nov 2015, 7:09 am
Back in 2009 – when the blog was still a Bexis/Herrmann operation – we wrote a catch-all punitive damages post entitled (oddly enough) “On Punitive Damages. [read post]
27 Jun 2008, 10:04 am
: (The Invent Blog), Impressive work on history of ‘Happy Birthday’ and copyright protection: (Innovationpartners), Gender and copyright: (Patry Copyright Blog)   Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 1-2 July – C5 conference on intellectual asset management for high-tech industries – Paris: (c5-online.com), 2… [read post]
4 Mar 2012, 9:02 am by Schachtman
Merrill Dow Pharmaceuticals, Inc., 874 F.2d 307, 311-12 (5th Cir. 1989)(“Fortunately, we do not have to resolve any of the above questions [as to bias and confounding], since the studies presented to us incorporate the possibility of these factors by the use of a confidence interval. [read post]
10 Apr 2008, 9:45 am
We don't have that much free time on our hands, since we're busy incorporating Colacicco into our pending briefs, for one thing.Colacicco, of course is only one opinion by one circuit court, so it's important to keep things in perspective - especially with the Supreme Court poised to tackle many of the same issues next term in the Levine case. [read post]